The Obesity Care Continuum (OCC) CONTINUES Discussions with the Food and Drug Administration (FDA) on Expanding Treatment Options for patients with Obesity
For Immediate Release
July 25, 2011
For More Information:
Washington, DC – On Monday, July 18, 2011, the Obesity Care Continuum (OCC), represented by The Obesity Society (TOS), the Obesity Action Coalition (OAC), the American Society for Metabolic and Bariatric Surgery (ASMBS) and the American Dietetic Association (ADA) again met with the FDA to discuss expanding treatment options for patients with serious medical obesity.
“We are very pleased that the FDA has taken the time to meet with the OCC to allow us to further elaborate on the need to help those struggling with significant health problems due to their obesity,” said Joe Nadglowski, Obesity Action Coalition (OAC) President and CEO.
FDA Participants in Monday’s meeting included Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research (CDER), and other senior CDER officials and representatives from the Endocronologic and Metabolic Drug Division. OCC and the FDA discussed numerous topics including improving the benefit risk ratio of obesity drugs by limiting the medications to those with serious obesity health related issues and ensuring that individuals who receive such medications do so as part of a comprehensive obesity management program. In addition, TOS presented a list of 40 obesity experts as potential Advisory Committee Members.
“The tenor of the meeting was positive with the FDA expressing an understanding of the profound impact obesity has on patient health and the significant benefit derived from a modest 5-10% weight loss. Furthermore, we are encouraged by the FDA’s commitment to continue working with obesity experts in finding safe solutions,” said Dr. Caroline Apovian, The Obesity Society.
The OCC is grateful that the FDA continues to dialogue with the obesity community to help ensure that the more than 90 million Americans affected by obesity have treatment options. Such options have the potential to prevent numerous obesity related deaths, lower cost of the chronic diseases associated with obesity and improve the lives of many Americans.
About the Obesity Care Continuum (OCC)
All of our organizations work together representing patients, registered dietitians, scientists, clinicians, and surgeons to elevate the recognition of both the prevention and treatment of obesity.
About the Obesity Action Coalition (OAC)
The OAC is a nonprofit, national charity dedicated to helping those affected by obesity. The OAC was formed to bring together individuals struggling with weight issues and provide educational resources and advocacy tools. Visit OAC at obesityaction.org.
About The Obesity Society (TOS)
The Obesity Society is the leading scientific society dedicated to the study of obesity. Since 1982, The Obesity Society has been committed to encouraging research on the causes and treatment of obesity, and to keeping the medical community and public informed of new advances. Visit TOS at obesity.org.
About the American Society for Metabolic and Bariatric Surgery (ASMBS)
The mission of the ASMBS is to advance the art and science of bariatric surgery by continued encouragement of its members to: improve the care and treatment of people with obesity and related diseases; advance the science and understanding of metabolic surgery; foster communication between health professionals on obesity and related conditions; and advocate for health care policy that ensures patient access to high-quality prevention and treatment of obesity. Visit ASMBS at asmbs.org.
About the American Dietetic Association (ADA)
The American Dietetic Association is the world’s largest organization of food and nutrition professionals. ADA is committed to improving the nation’s health and advancing the profession of dietetics through research, education and advocacy. Visit ADA at eatright.org.